{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:06:01Z","timestamp":1775714761719,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>Acute graft\u2010versus\u2010host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) is mediated by grafted T lymphocytes after their polarization into type 1 T cells. Interleukin (IL)\u201018, a novel immunoregulatory cytokine, strongly stimulates type 1 T cells, therefore we postulated that IL\u201018 may be involved in the pathogenesis of aGVHD. Using an enzyme\u2010linked immunosorbent assay (ELISA), we serially measured serum levels of IL\u201018 in 37 patients with haematological malignancy before and after allogeneic BMT. Patients with aGVHD had high levels of IL\u201018 that strongly correlated with the severity of aGVHD. We also found that they showed reduced serum levels of IL\u201018 after appropriate treatment or at a state of resolution. IL\u201018 levels were not affected by the pretransplant regimen, engraftment or bacterial infection. Compared with circulating interferon (IFN)\u2010\u03b3 or IL\u201012 levels, serum levels of IL\u201018 showed a more sensitive and specific correlation with the disease status of aGVHD. These findings suggest that IL\u201018 may play important roles in the pathogenesis of aGVHD and that measurement of serum IL\u201018 levels can be useful indicator of aGVHD.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02095.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:24:24Z","timestamp":1047363864000},"page":"652-657","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Elevated interleukin (IL)\u201018 levels during acute graft\u2010versus\u2010host disease after allogeneic bone marrow transplantation"],"prefix":"10.1111","volume":"109","author":[{"given":"Yoshihiro","family":"Fujimori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Kakishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"389","article-title":"Serum interleukin\u201012 levels in patients undergoing allogeneic or autologous bone marrow transplantation","volume":"7","author":"Bonnotte B.","year":"1996","journal-title":"European Cytokine Network"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291703"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0272"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.63.6.658"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2118"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.003035"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5297.206"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.4049\/jimmunol.157.7.2851","article-title":"IL\u201012 p40 messenger RNA expression in target organs during acute graft\u2010versus\u2010host disease. Possible involvement of IFN\u2010gamma","volume":"157","author":"Kichian K.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198709000-00002"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02918284"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199708270-00001"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199010000-00019"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.162.6.3202","article-title":"Development of CD8+ effector T cells is differentially regulated by IL\u201018 and IL\u201012","volume":"162","author":"Okamoto I.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/378088a0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80163-5"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60389-2"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4049\/jimmunol.160.3.1166","article-title":"IL\u201012 up\u2010regulates CD40 ligand (CD154) expression on human T cells","volume":"160","author":"Peng X.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","article-title":"IL\u201018, a novel immunoregulatory cytokine, is up\u2010regulated in Crohn's disease: expression and localization in intestinal mucosal cells","volume":"162","author":"Pizarro T.T.M.H.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92848-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.31.19569"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01504.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(97)00094-X"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001343"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.157.9.3967","article-title":"IFN\u2010\u03b3\u2010inducing factor up\u2010regulates Fas ligand\u2010mediated cytotoxic activity of murine natural killer cell clones","volume":"157","author":"Tsutsui H.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.153.9.4040","article-title":"IL\u201012 stimulates the development of acute graft\u2010versus\u2010host disease in mice that normally would develop chronic, autoimmune graft\u2010versus\u2010host disease","volume":"153","author":"Via C.S.","year":"1994","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.157.2.689","article-title":"IL\u201012 is a central mediator of acute graft\u2010versus\u2010host disease in mice","volume":"157","author":"Williamson E.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.8.1485"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL\u201012 up\u2010regulates IL\u201018 receptor expression on T cells, Th1 cells, and B cells: synergism with IL\u201018 for IFN\u2010gamma production","volume":"61","author":"Yoshimoto T.","year":"1998","journal-title":"Journal of Immunology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02095.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02095.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02095.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:27:53Z","timestamp":1698578873000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02095.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02095.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02095.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}